“…Many factors, including drugs (Flower, 1974), proteinmodifying agents, zinc and copper metal ions (Sakuma et al, 1990(Sakuma et al, , 1996, hyperoxia (Parkes and Eling, 1975;Chaudhari et al, 1979;Vader et al, 1981;Pisarello et al, 1997), fatty acids, cAMP (Lennon et al, 1999), calcium, bacterial endotoxins (lipopolysaccharide) (Alam et al, 1973;Nakano and Prancan, 1973;Blackwell et al, 1976;Harper et al, 1980;Hahn et al, 1998), 1,25-dihydroxyvitamin D3 (Pichaud et al, 1997), vitamin E (Chan et al, 1980, thyroid hormones (Tai et al, 1974;Moore and Hoult, 1978), cytokines (Brown et al, 1998) and steroid hormones, have been implicated in the regulation of PGDH activity in a variety of species and types of cell (Nakano and Prancan, 1973;Andersen and Ramwell, 1974;Lee and Levine, 1975;Hansen, 1976;Tai and Hollander, 1976;Pace-Asciak and Smith, 1983;Krook et al, 1992;Okita and Okita, 1996). The 1.6 kb promoter region of the PGDH gene contains two TATA boxes and a number of potential regulatory elements, including Sp1, CRE, GRE, AP1, AP2, NF-IL6, C-MYC and a putative oestrogen receptor binding site (Matsuo et al, 1996(Matsuo et al, , 1997.…”